Skip to search formSkip to main contentSkip to account menu

Refractory Follicular Lymphoma

Follicular lymphoma grade I, II, III that is resistant to treatment.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
EFFICACY AND SAFETY OF OBINUTUZUMAB + LENALIDOMIDE + ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA… 
2019
2019
treated with the Bruton tyrosine kinase (BTK) inhibitor ibrutinib, intolerance was the most common reason for discontinuation (50… 
2017
2017
Scientific support was provided by Grace Ku, MD, of Genentech, Inc. Editorial assistance for this poster was provided by Anne… 
2015
2015
Three sequential phase II trials were conducted with different immunotherapy approaches to enhance the outcome of autologous… 
2015
2015
Allogeneic stem cell transplantation (allo-SCT) is a curative option for patients with relapsed follicular lymphoma (FL… 
2013
2013
TPS8614^ Background: Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma (NHL) and comprises approximately 22… 
2013
2013
Allogeneic hematopoietic stem cell transplantation (allo-SCT) is considered the only curative treatment for relapsed or… 
2009
2009
PURPOSE In this study, we sought to evaluate the efficacy and toxicity of high-dose therapy followed by autologous peripheral… 
2001
2001
Seventeen patients with refractory follicular lymphoma heavily treated with chemotherapy (>2 regimens), radiotherapy, and…